NCT02300259View on ClinicalTrials.gov

A Study of LY2623091 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

LY2623091

Administered orally

DRUG

Itraconazole

Administered orally

DRUG

Simvastatin

Administered orally

DRUG

Tadalafil

Administered orally

DRUG

Diltiazem

Administered orally

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02300259 - A Study of LY2623091 in Healthy Participants | Biotech Hunter | Biotech Hunter